✦ LIBER ✦

5.15 Resistance to Complement-Dependent Cytotoxicity in Chronic Lymphocytic Leukemia Cells from Patients Treated with Ofatumumab

✍ Scribed by Nisar A. Baig; Ronald P. Taylor; Margaret A. Lindorfer; Amy K. Church; Betsy R. LaPlant; Emily S. Pavey; Tait D. Shanafelt; Timothy G. Call; Neil E. Kay; Grzegorz S. Nowakowski; Clive S. Zent

Book ID: 119218960
Publisher: Elsevier
Year: 2011
Tongue: English
Weight: 217 KB
Volume: 11
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2011.09.169

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Complement dependent cytotoxicity in chr

Complement dependent cytotoxicity in chronic lymphocytic leukemia: ofatumumab enhances alemtuzumab complement dependent cytotoxicity and reveals cells resistant to activated complement

✍ Baig, Nisar A.; Taylor, Ronald P.; Lindorfer, Margaret A.; Church, Amy K.; Lapla 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 436 KB

Induced Resistance to Ofatumumab-Mediate

Induced Resistance to Ofatumumab-Mediated Cell Clearance Mechanisms, Including Complement-Dependent Cytotoxicity, in Chronic Lymphocytic Leukemia

✍ Baig, N. A.; Taylor, R. P.; Lindorfer, M. A.; Church, A. K.; LaPlant, B. R.; Pet 📂 Article 📅 2014 🏛 American Association of Immunologists 🌐 English ⚖ 760 KB

Direct and complement dependent cytotoxi

Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early–intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab

✍ Clive S. Zent; Charla R. Secreto; Betsy R. LaPlant; Nancy D. Bone; Timothy G. Ca 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 373 KB

The mechanism of cytotoxicity of alemtuzumab and rituximab in chronic lymphocytic leukemia (CLL) is not well understood. We obtained fresh CLL cells from early-intermediate stage high-risk patients just prior to treatment with alemtuzumab and rituximab to study mechanisms of action and resistance. A

Alemtuzumab induces enhanced apoptosis i

Alemtuzumab induces enhanced apoptosis in vitro in B-cells from patients with chronic lymphocytic leukemia by antibody-dependent cellular cytotoxicity

✍ Holger Nückel; Ulrich H. Frey; Alexander Röth; Ulrich Dührsen; Winfried Siffert 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 200 KB

Quantitative analyses reveal substantial

Quantitative analyses reveal substantial differences between Ofatumumab (OFA) and Rituximab (RTX) in mediating Complement-Dependent Cytotoxicity (CDC) of B cell lines and Chronic Lymphocytic Leukemia (CLL) cells

✍ P. Taylor 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Selectively frequent expression of CXCR5

Selectively frequent expression of CXCR5 enhances resistance to apoptosis in CD8+CD34+ T cells from patients with T-cell-lineage acute lymphocytic leukemia

✍ Qiuping, Zhang; Jie, Xiong; Youxin, Jin; Qun, Wu; Wei, Ju; Chun, Liu; Jin, Wang; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 452 KB